Friday December 13, 2019

Diabetes Medication to Reduce Heart Disease Shows Promise: Researchers

The results are applicable primarily to dapagliflozin, which was the predominant SGLT2 inhibitor used in Scandinavia during the study period

0
//
diabetes
Diabetes is the ninth leading cause of death in women and claims 2.1 million female lives every year, more so than men. Pixabay

Researchers, including one of an Indian-origin, have shed light on how a class of medications that help regulate blood sugar for patients with Type 2 diabetes can also protect from heart disease.

The findings published in the journal Cell Metabolism, focus on the effect of diabetes medication — empagliflozin — on cell repair in blood vessels and the resulting risks of heart disease.

Empagliflozin is a medication that falls under a category of drugs called SGLT2 inhibitors, which lower blood sugar.

“We have seen large-scale clinical trials giving us clear evidence that SGLT2 inhibitors can also protect our patients who have diabetes from heart disease,” said Indian-origin researcher and study author Subodh Verma from St. Michael’s Hospital in Canada.

The research suggests that circulating progenitor cells — which are found in the bone marrow and play a role in heart health — along with inflammatory cells are regulated with this diabetes medication.

For patients who have diabetes are at the risk of heart disease, such medications may provide heart protection by relieving damaged cells that would otherwise perpetuate heart disease by causing faulty vessel repair.

Diabetes
According to the researchers, these novel findings may provide the basis for new therapies for patients who have heart disease complicated by diabetes. Pixabay

Using blood samples from the EMPA-HEART CardioLink-6 Trial, the research team was able to show that in diabetes, regenerative progenitor cells were reduced.

Patients who took empagliflozin, however, these progenitor cells were restored later.

“We found that in people with diabetes, not only were beneficial progenitor cells increased but we saw indications of reduced inflammation and oxidative stress, which can also contribute to cardiovascular disease,” said David Hess, Associate Professor at Western University.

According to the researchers, these novel findings may provide the basis for new therapies for patients who have heart disease complicated by diabetes.

Also Read: Social Networking Giant Facebook Plans Test to Let Users Hide ‘Like’ Counts

Earlier a research from Karolinska Institute in Sweden said that the new type of drugs for type 2 diabetes — SGLT2 inhibitors — are associated with a reduced risk of heart failure by 34 per cent.

The results are applicable primarily to dapagliflozin, which was the predominant SGLT2 inhibitor used in Scandinavia during the study period. (IANS)

Next Story

Intermittent Fasting Benefits Those at Risk for Diabetes: Study

Time-restricted eating benefits those at risk for diabetes

0
Diabetes
People at risk of developing diabetes should practice intermittent fasting. Pixabay

Researchers have found that people who are at high risk of developing diabetes improved their health when they consumed all of their meals over a span of just 10 hours, or less over a period of 12 weeks.

The study published in the journal cell Metabolism, reported a form of intermittent fasting, called time-restricted eating, improved the health of study participants who had been diagnosed with metabolic syndrome.

Metabolic syndrome is the name for a group of risk factors, such as high blood pressure and cholesterol levels, that increase the risk for adverse health issues, from heart disease and diabetes to stroke.

The researchers from University of California in US, found that when participants restricted their eating to 10 hours or less over a period of 12 weeks, they lost weight, reduced abdominal fat, lowered blood pressure and cholesterol and enjoyed more stable blood sugar and insulin levels.

Diabetes risks
Time-restricted eating can improve the health of those with diabetes. Pixabay

“Time-restricted eating is a simple dietary intervention to incorporate, and we found that participants were able to keep the eating schedule,” said study co-author Satchin Panda from the University of California in US.

“Eating and drinking everything (except water) during a 10-hour window allows your body to rest and restore for 14 hours at night. Your body can also anticipate when you will eat, so it can prepare the body to optimize metabolism,” Panda added.

Time-restricted eating (eating all calories within a consistent 10-hour window) allows individuals to eat in a manner that supports their circadian rhythms and their health.

Circadian rhythms are the 24-hour cycles of biological processes that affect nearly every cell in the body.

Erratic eating patterns can disrupt this system and induce symptoms of metabolic syndrome, including increased abdominal fat and abnormal cholesterol or triglycerides.

The study involved 19 participants diagnosed with metabolic syndrome, with 16 taking at least one medication, like a statin.

Diabetes risk factor
Metabolic syndrome is the name for a group of risk factors that includes diabetes. Pixabay

Participants used an app created by Panda called myCircadianClock to log when and what they ate during an initial two-week baseline period followed by three months of 10-hour time-restricted eating per day.

They were told they could decide what time to eat and how much to eat as long as all food consumption occurred within a 10-hour window.

At the end of the 12 weeks, participants averaged a three per cent reduction in weight and body mass index (BMI) and a four per cent reduction in abdominal/visceral fat.

Many also experienced reductions in cholesterol and blood pressure and improvements in fasting glucose. Seventy percent of participants reported an increase in sleep satisfaction or in the amount they slept.

Also Read- Parents With Single Child More Likely to Tackle an Obese Kid: Study

“Patients also reported that they generally had more energy, and some were able to have their medications lowered or stopped after completing the study,” said study researcher Pam Taub from University of California. (IANS)